List Labs Bacterial Toxin & Vaccine Research Blog

SEB, superantigen of choice for positive control for cytokine detection

January 25, 2016

By: douano@listlabs.com

By: Grace Ayabe, Technical Support Would you like a positive control for production of cytokines in human peripheral blood mononuclear cells (PBMC’s)? If your laboratory is testing for cytokine production, List Labs can provide you with SEB (Staphylococcus aureus, Enterotoxin Type B) to stimulate a positive response to assure that your cells are functional. SEB […]

Read more

Epsilon Toxin: A Fascinating Pore Forming Toxin That Crosses The Blood Brain Barrier

January 11, 2016

By: douano@listlabs.com

By: Md. Elias Ph.D, Senior Scientist Epsilon Toxin Linked to Multiple Sclerosis List Labs recently added Product #126A, pure Native C. perfringens Epsilon Toxin to its product line. Although Epsilon Toxin related pathology and disease are common in farm animals and rare in humans, recent studies suggest potential involvement of this toxin with Human Multiple Sclerosis (MS), an [...]

Read more

Become a List Labs Customer in 3 Easy Steps

October 19, 2015

By: douano@listlabs.com

By: Dom C. Ouano, Marketing Associate Since 1978, List Labs has developed over 100 toxins and reagents for research. Our facility has BSL2 and BSL3 laboratories appropriate for the production of a wide variety of toxins, making safety and security top priorities. Therefore, we have processes in place that we must follow to comply with regulations. […]

Read more

Opening Dangerous Goods Containers & Vials In 4 Steps

August 10, 2015

By: douano@listlabs.com

By: Dom C. Ouano, Marketing Associate Debby Renshaw, Shipping Manager Kim Krause, Laboratory Support Supervisor Below is a list of recommended steps on handling List Labs products upon receiving them. It should be noted that these are simply our own suggestions. If your institution has a standard protocol in place, we ask that you follow said standard […]

Read more

GMP Grade vs. Reagent Grade

June 22, 2015

By: douano@listlabs.com

By: Karen Crawford, Ph.D., President Eva Purro, Director of Quality Assurance Dom C. Ouano, Marketing While most of List Labs’ products are intended as research reagents (Research Grade), several can be produced as GMP products for use in humans. Below are key differences between the two. Research Only VS Preclinical/Clinical/Human Use Reagent grade products for […]

Read more

Vaccine Development for the Control of Bordetella Pertussis Infections (Whooping Cough)

April 6, 2015

By: List Labs

By: Suzanne Canada, Ph.D. Tanager Medical Writing Concerns over outbreaks of potentially serious childhood diseases are in the news again in California with an increase in whooping cough infections in 2014, caused by the pathogen Bordetella pertussis, and a measles outbreak in December 2014 to February 2015. Since outbreaks and epidemics may be infrequent, many […]

Read more